Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0ZL1T
|
|||
Former ID |
DIB014668
|
|||
Drug Name |
SK-NBP601
|
|||
Synonyms |
NBP-601
Click to Show/Hide
|
|||
Indication | Hemophilia [ICD-11: 3B10.0; ICD-10: D66-D68; ICD-9: 286] | Preregistration | [1] | |
Company |
SK Chemicals Co Ltd
|
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Coagulation factor VIII (F8) | Target Info | Inhibitor | [2] |
KEGG Pathway | Complement and coagulation cascades | |||
Panther Pathway | Blood coagulation | |||
Pathwhiz Pathway | Coagulation | |||
Reactome | Platelet degranulation | |||
Intrinsic Pathway of Fibrin Clot Formation | ||||
Common Pathway of Fibrin Clot Formation | ||||
COPII (Coat Protein 2) Mediated Vesicle Transport | ||||
Cargo concentration in the ER | ||||
WikiPathways | Complement and Coagulation Cascades | |||
Blood Clotting Cascade | ||||
Formation of Fibrin Clot (Clotting Cascade) |
References | Top | |||
---|---|---|---|---|
REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800035403) | |||
REF 2 | Clinical pipeline report, company report or official report of SK Chemicals. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.